major depressive disorder. Major depressive disorder, single episode
Conditions
Interventions
Intervention 1: Intervention group: Citalopram tablet was given 20 mg once a day for 6 weeks and Vareniclin tablet (produced by Kowsar Pharmacy Company) 0.5 mg daily for the first three days and then
Sponsors
Yazd University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to 60 Years
Inclusion criteria
Inclusion criteria: Persons in ranged 18 to 60 years old Smokers under methadone maintenance therapy Patients with Major depressive disorder
Exclusion criteria
Exclusion criteria: The patient's desire to withdraw from the study Create a noticeable and persistent drug problem Have a systemic disease Patients with substance use (Based on Self-report) Patients with psychotic disorder Patients with suicidal thoughts The patients under treatment with psychiatric drugs Depression is follow to substance use Depression is associated with medical illness The patient is taking drugs that cause depression
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Depression Score. Timepoint: First, 3 weeks later, 6 weeks later. Method of measurement: Beck Depression Inventory(I-II). | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactDr. Ghasem Dastjerdi
Yazd University of Medical Sciences
Outcome results
None listed